| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.27 | 9e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |